查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301036

RNA 分析市場規模、份額和趨勢分析報告：按產品（試劑盒和試劑、服務、儀器）、按技術（qPCR、微陣列、測序）、按應用、按最終用途、細分趨勢，2023-2030 年

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

RNA 分析市場增長和趨勢

Grand View Research, Inc. 的新報告預測，到 2030 年，全球 RNA 分析市場規模將達到 202.1 億美元，複合年增長率預計將達到 10.86%，創歷史新高

轉錄組學是後基因組時代的前沿領域之一。 該行業的技術進步源於生命科學中越來越多地應用轉錄組測序來捕獲多腺甘酸化 RNA。 隨著下一代高通量測序技術的擴展，轉錄組分析正在逐步提高我們對基於 RNA 的基因調控網絡的理解。 例如，2021 年 7 月，立陶宛的一個研究團隊正在開發一種基於液滴的技術，可同時捕獲單個細胞內的 mRNA 和 microRNA 並進行測序。

這項研究已獲得歐盟 (EU) 提供的 174,000 美元 Horizo□□n 2020 研究補助金。 此外，2022 年 5 月，CD Genomics 宣布了數字 RNA 測序技術，這是一種基於 NGS 的方法，消除了序列依賴性 PCR。 通過這些努力，市場增長預計將很快加速。 核糖核酸轉錄組分析使研究人員能夠分析基因在生物體中的位置以及特定基因的功能模式。 該方法用於評估所有轉錄本在發育階段的變化行為，並分析轉錄本的所有元素，包括信使核糖核酸、非編碼核糖核酸和微核糖核酸，以鑑定基因的轉錄結構。

分析大量基因以了解基因與藥物相互作用的需求日益增長，預計將加強轉錄組學技術在發現和藥物開發中的應用。 例如，正在分析 COVID-19 患者的轉錄組概況，以檢查疾病預後和管理。 此外，對個性化藥物的需求不斷增長預計將在預測期內推動該行業的增長。 2020年4月，Caris Life Sciences宣布已向美國FDA提交MI Transcriptome CDx的上市前申請。 這是一種強大的精密醫學檢測方法，包含重要的伴隨診斷生物標誌物。 同時，轉錄組研究中缺乏數據管理和有效的生物信息學工具是該行業的主要挑戰之一。

高通量技術的發展為全面了解複雜的生物過程提供了獨特的機會。 儘管組學數據有相當多的可用性，但將生物數據轉化為具有臨床價值的知識仍然是主要挑戰之一。 這不僅是由於當前的數據處理和集成方法不足，而且是由於現有分析方法的應用不充分。 據報導，由於公司對製藥和生物技術研究的投資增加，北美將成為 2021 年創收最高的地區。 由於製造服務成本低廉，亞太地區預計 2022 年至 2030 年復合年增長率最快。

RNA 分析市場報告亮點

  • 到 2022 年，實時 PCR (qPCR) 將佔據技術領域的主要市場份額，並且預計在預測期內將延續這一趨勢。
  • 由於測序技術的進步和 NGS 技術接受度的提高等因素，轉錄組測序技術預計在預測期內將實現大幅複合年增長率。
  • 由於轉錄組研究中耗材的利用率較高，試劑盒和試劑部門在 2022 年的收入份額最高。
  • 傳染病和病原體細分市場將在 2022 年佔據最大份額，並且預計在預測期內將繼續保持這一趨勢。
  • 傳染病流行的加劇是推動該細分市場增長的主要因素。
  • 隨著越來越多的機構和中心利用高通量技術進行高效且有效的核糖核酸分析流程，政府機構和學術中心在最終用戶領域佔據主導地位。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
    • 信息分析
    • 市場形成和數據可視化
    • 驗證和發布數據
  • 調查假設
  • 信息獲取
    • 初步調查
  • 信息或數據分析
  • 市場形成和驗證
  • 市場模式
  • 全球市場：計算複合年增長率
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 行業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影響分析

第四章產品業務分析

  • RNA 分析市場：產品變異分析
  • 設備
    • 2018-2030 年設備市場（百萬美元）
  • 試劑盒和試劑
    • 試劑盒和試劑市場，2018-2030 年（百萬美元）
    • miRNA 和 siRNA
    • 逆轉錄□和 RT-PCR
    • RNA提取和純化
    • RNA干擾
    • 其他
  • 服務
    • 2018-2030 年服務市場（百萬美元）

第 5 章技術業務分析

  • RNA分析市場：技術波動分析
  • 實時熒光定量 PCR (qPCR)
    • 實時 PCR (qPCR) 市場，2018-2030 年（百萬美元）
  • 微陣列芯片
    • 2018-2030 年微陣列市場（百萬美元）
  • 序列
    • 測序市場，2018-2030 年（百萬美元）
  • 其他
    • 其他技術市場，2018-2030 年（百萬美元）

第六章應用業務分析

  • RNA 分析市場：應用變異分析
  • RNA表達圖譜的構建
    • 2018-2030 年構建 RNA 表達圖譜的市場（百萬美元）
  • 表觀遺傳學
    • 表觀遺傳學市場，2018-2030 年（百萬美元）
  • 傳染病和致病性
    • 傳染病和病原體市場，2018-2030 年（百萬美元）
  • 選擇性 RNA 剪接
    • 替代性 RNA 剪接市場，2018-2030 年（百萬美元）
  • RNA結構和分子動力學
    • 2018-2030 年 RNA 結構和分子動力學市場（百萬美元）
  • 開發和提供 RNA 療法
    • 2018-2030 年 RNA 療法開發和交付市場（百萬美元）
  • 其他
    • 其他應用市場，2018-2030 年（百萬美元）

第 7 章：最終用途業務分析

  • 政府機構和學術中心
    • 政府和學術中心市場，2018-2030 年（百萬美元）
  • 製藥和生物技術公司
    • 2018-2030 年製藥和生物技術企業市場（百萬美元）
  • 醫院和診所
    • 醫院和診所市場，2018-2030 年（百萬美元）
  • 委託研究組織 (CRO)
    • 合同研究組織 (CRO) 市場，2018-2030 年（百萬美元）

第 8 章區域業務分析

  • 2022 年和 2030 年按地區劃分的 RNA 分析市場份額
  • 北美
    • 2018-2030 年北美 RNA 分析市場（百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲 RNA 分析市場（百萬美元）
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區 RNA 分析市場（百萬美元）
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲 RNA 分析市場，2018-2030 年（百萬美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • MEA RNA 分析市場，2018-2030 年（百萬美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 9 章競爭格局

  • 公司分類
  • 戰略規劃
  • 2022 年公司市場份額分析
  • 公司簡介/列表
    • Agilent Technologies, Inc
    • F. Hoffmann-La Roche AG
    • Illumina, Inc.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Eurofins Scientific
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Pacific Bioscience of California, Inc.;
    • Affymetrix, Inc.
    • Danaher
    • Promega
Product Code: 978-1-68038-534-2

RNA Analysis Market Growth & Trends

The global RNA analysis market size is expected to reach USD 20.21 billion by 2030, registering a CAGR of 10.86% according to a new report by Grand View Research, Inc.. Transcriptomics is one of the most advanced fields in the post-genomic period. Technological advancements in this industry can be attributed to the increasing applications of transcriptome sequencing in life science for capturing polyadenylated RNA. With the expansion of next-generation high-throughput sequencing technology, the analysis of transcriptomes has been gradually improving the understanding of the regulatory network of RNA-based genes. For instance, in July 2021, the Lithuanian team is developing a droplet-based technique for simultaneous mRNA and microRNA capture and sequencing in a single cell.

The research is backed by the European Union with a USD174,000 Horizon 2020 research grant. Moreover, in May 2022, CD Genomics launched the Digital RNA sequencing technology, which is an NGS-based method that excludes sequence-dependent PCR. Such initiatives are anticipated to accelerate market growth shortly. Ribonucleic acid transcriptome analysis enables the researchers to analyze the position of genes as well as the functional patterns of a specific gene in an organism. The method assists in evaluating every transcript's changing behavior at the development stage and assesses all the elements of a transcript, including messenger ribonucleic acid, non-coding ribonucleic acid, and micro ribonucleic acid, for identifying the transcriptional structure of genes.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Furthermore, increasing demand for personalized medicines is anticipated to fuel the industry growth during the forecast period. In April 2020, Caris Life Sciences announced the submission of Pre-Market Approval applications for MI Transcriptome CDx to the USFDA. It is a powerful precision medicine assay, which contains significant companion diagnostic biomarkers. On the other hand, data management in transcriptomic research and the lack of effective bioinformatics tools are some of the major challenges in the industry.

The evolution of high-throughput technologies has provided invaluable opportunities for generating holistic views of complex biological processes. Despite the considerable availability of omics data, the conversation of biological data into clinically valuable knowledge remains one of the major challenges. It is not only because of insufficient current data processing or integration methods but also for inappropriate application of existing analysis approaches. North America has been reported as the highest revenue-generating region in 2021 owing to increasing investments in pharmaceutical and biotechnology research by corporations. Asia Pacific is projected to register the fastest CAGR from 2022 to 2030 owing to the low-cost manufacturing services.

RNA Analysis Market Report Highlights

  • Real-Time- PCR (qPCR) accounted for the major market share in the technology segment in 2022 and is said to continue the trend during the forecast period owing to the increasing use of PCR for COVID-19 diagnostic across the globe
  • The transcriptome sequencing technology is estimated to register a significant CAGR during the forecast period owing to factors, such as advancements in sequencing technology and growing acceptance of NGS technology
  • The kits and reagents segment accounted for the highest revenue share in 2022 owing to a high utilization rate of consumables during transcriptomic studies
  • The infectious diseases and pathogenesis segment accounted for the largest share in 2022 and is anticipated to have a similar trend during the forecasted period
  • The increasing prevalence of the infectious disease is the major factor driving the segment growth
  • Government institutes & academic centers dominated the end-user segment as the increasing number of institutes and centers leveraged high throughput technologies for the effective and efficient process of ribonucleic acid analysis

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
      • 3.2.1.2. Rising Diagnostic Utility Of Transcriptomics Technologies
      • 3.2.1.3. Advent of Novel Approaches for Understanding Gene Expression at RNA Level
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Higher Cost of Research & Developments
      • 3.2.2.2. High Costs Associated With Analysis Platforms
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. RNA Analysis Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
    • 4.3.2. miRNA & siRNA
      • 4.3.2.1. miRNA & siRNA Market, 2018 - 2030 (USD Million)
    • 4.3.3. Reverse Transcriptases & RT-PCR
      • 4.3.3.1. Reverse Transcriptases & RT-PCR Market, 2018 - 2030 (USD Million)
    • 4.3.4. RNA Extraction & Purification
      • 4.3.4.1. RNA Extraction & Purification Market, 2018 - 2030 (USD Million)
    • 4.3.5. RNA Interference
      • 4.3.5.1. RNA Interference Market, 2018 - 2030 (USD Million)
    • 4.3.6. Others
      • 4.3.6.1. Other Kits & Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. RNA Analysis Market: Technology Movement Analysis
  • 5.2. Real Time-PCR (qPCR)
    • 5.2.1. Real Time-PCR (qPCR) Market, 2018 - 2030 (USD Million)
  • 5.3. Microarray
    • 5.3.1. Microarray Market, 2018 - 2030 (USD Million)
  • 5.4. Sequencing
    • 5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other Technologies Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. RNA Analysis Market: Application Movement Analysis
  • 6.2. Construction of RNA Expression Atlas
    • 6.2.1. Construction of RNA Expression Atlas Market, 2018 - 2030 (USD Million)
  • 6.3. Epigenetics
    • 6.3.1. Epigenetics Market, 2018 - 2030 (USD Million)
  • 6.4. Infectious Diseases & Pathogenesis
    • 6.4.1. Infectious Diseases & Pathogenesis Market, 2018 - 2030 (USD Million)
  • 6.5. Alternative RNA Splicing
    • 6.5.1. Alternative RNA Splicing Market, 2018 - 2030 (USD Million)
  • 6.6. RNA Structure & Molecular Dynamics
    • 6.6.1. RNA Structure & Molecular Dynamics Market, 2018 - 2030 (USD Million)
  • 6.7. Development & Delivery of RNA Therapeutics
    • 6.7.1. Development & Delivery of RNA Therapeutics Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Government Institutes & Academic Centers
    • 7.1.1. Government Institutes & Academic Centers Market, 2018 - 2030 (USD Million)
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.4. Contract Research Organizations (CROs)
    • 7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. RNA Analysis Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. North America RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. U.S. RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Canada RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. UK RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Germany RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. France RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Italy RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Spain RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Denmark RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Sweden RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Norway RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Japan RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. China RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. India RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Australia RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Thailand RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. South Korea RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Brazil RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Mexico RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Argentina RNA Analysis Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. South Africa RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Saudi Arabia RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. UAE RNA Analysis Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Kuwait RNA Analysis Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. Agilent Technologies, Inc
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche AG
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Illumina, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Eurofins Scientific
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Bio-Rad Laboratories, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Pacific Bioscience of California, Inc.;
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Affymetrix, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Danaher
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Promega
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global RNA analysis market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global RNA analysis market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global RNA analysis market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global RNA analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Global RNA analysis market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 8 North America RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 9 North America RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 10 North America RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 14 U.S. RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 15 Canada RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 16 Canada RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 17 Canada RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 18 Canada RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 20 Europe RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 21 Europe RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 22 Europe RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 24 Germany RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 25 Germany RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 26 Germany RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 27 U.K. RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 28 U.K. RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 29 U.K. RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 30 U.K. RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 31 France RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 32 France RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 33 France RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 34 France RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 35 Italy RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 36 Italy RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 37 Italy RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 38 Italy RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 39 Spain RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 40 Spain RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 41 Spain RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 42 Spain RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 43 Denmark RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 44 Denmark RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 45 Denmark RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 47 Sweden RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 48 Sweden RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 49 Sweden RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 50 Sweden RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 51 Norway RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 52 Norway RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 53 Norway RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 54 Norway RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 59 China RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 60 China RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 61 China RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 62 China RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 63 Japan RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 64 Japan RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 65 Japan RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 66 Japan RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 67 India RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 68 India RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 69 India RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 70 India RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 71 Australia RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 72 Australia RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 73 Australia RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 74 Australia RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 75 Thailand RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 76 Thailand RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 77 Thailand RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 78 Thailand RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Korea RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 80 South Korea RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 82 South Korea RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 83 Latin America RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 84 Latin America RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 85 Latin America RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 86 Latin America RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 87 Brazil RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 88 Brazil RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 89 Brazil RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 90 Brazil RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 91 Mexico RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 92 Mexico RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 93 Mexico RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 94 Mexico RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 95 Argentina RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 96 Argentina RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 97 Argentina RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 98 Argentina RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 99 MEA RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 100 MEA RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 101 MEA RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 102 MEA RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 103 South Africa RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 111 UAE RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 112 UAE RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 113 UAE RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 114 UAE RNA analysis market by end-use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait RNA analysis market by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait RNA analysis market by technology, 2018 - 2030 (USD Million)
  • Table 117 Kuwait RNA analysis market by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait RNA analysis market by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 RNA analysis market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 RNA analysis market: Products outlook and key takeaways
  • Fig. 15 RNA analysis market: Product movement analysis
  • Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 miRNA and siRNA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Reverse transcriptase & RT-PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 RNA extraction & purification market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 RNA interference market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 RNA analysis market: Technology outlook and key takeaways
  • Fig. 25 RNA analysis market: Technology movement analysis
  • Fig. 26 Real time-PCR (qPCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 RNA analysis market: Application outlook and key takeaways
  • Fig. 31 RNA analysis Market: Application movement analysis
  • Fig. 32 Construction of RNA expression atlas market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Infectious diseases and pathogenesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Alternative RNA splicing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 RNA structure and molecular dynamics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Development and delivery of RNA therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Others applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 RNA analysis market: End-use outlook and key takeaways
  • Fig. 40 RNA analysis market: End-use movement analysis
  • Fig. 41 Government institutes & academic centers estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmaceutical & biotechnology companies estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hospitals & clinics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Contract Research Organizations (CROs) estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 RNA analysis market: Regional outlook and key takeaways
  • Fig. 46 RNA analysis market: Regional movement analysis
  • Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)